Artemis Medicare Services Share Price Today (ARTEMISMED)
TODAY IN ONE LINE
ARTEMISMED rose 1.4% on light volume, outperforming Nifty's 0.1% move, supported by recent strong earnings.
With a market cap of ₹4,412.79 Cr., it trades at a P/E of 42.14. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Artemis Medicare Services flags
Key strengths and potential risks.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 28.7% YoY
- ●Quarterly OutperformanceLatest quarter Sales up 16.4% and Profit up 30.4%
- ●Healthy Operating MarginsOPM is structurally strong at 17.4%
- ●High Promoter HoldingPromoters hold 58.4% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
No red flags identified
What changed recently?
Recent events, corporate actions, and announcements.
Artemis Medicare Services Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Artemis Medicare Services Limited, framed against the sector median so the premium or discount is obvious at a glance.
Artemis Medicare Services Limited trades at a P/E of 42.14× and P/B of 4.67×.
Valuation
Profitability
Growth
Financial Health
Artemis Medicare Services Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Artemis Medicare Services Limited — derived from the live tape, not yesterday's close.
Artemis Medicare Services Limited last traded at ₹276.2 with an intraday range of ₹271.05–₹279.8 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹276.20| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 297.82 | +21.62 | +7.83% |
| R3 | 289.07 | +12.87 | +4.66% |
| R2 | 284.43 | +8.23 | +2.98% |
| R1 | 280.32 | +4.12 | +1.49% |
| PIVOT | 275.68 | -0.52 | -0.19% |
| CURRENT | 276.20 | — | — |
| S1 | 271.57 | -4.63 | -1.68% |
| S2 | 266.93 | -9.27 | -3.36% |
| S3 | 262.82 | -13.38 | -4.85% |
| S4 | 254.07 | -22.13 | -8.01% |
ARTEMISMED is trading Above CPR, indicating Bullishness
CPR is Average
Day's range: ₹271.05–₹274.5
Trading Inside opening range
Artemis Medicare Services Limited financials: P&L, balance sheet, cash flow, ratios.
Twelve years of audited numbers for Artemis Medicare Services Limited, switchable between annual and quarterly views, consolidated or standalone.
Artemis Medicare Services Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹4,412.79 Cr. and reported EPS of ₹2.29.
| Period | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | 565 | 408 | 555 | 737 | 879 | 937 | 1,081 |
| Other Income | 5 | 4 | 4 | 7 | 7 | 33 | 30 |
| Total Income | 570 | 412 | 559 | 745 | 886 | 970 | 1,111 |
| Cost of Goods Sold (COGS) | 139 | 116 | 342 | 195 | 219 | 227 | 254 |
| Gross Profit | 426 | 292 | 213 | 543 | 660 | 709 | 827 |
| +Operating Expenses | 365 | 257 | 146 | 449 | 527 | 558 | 639 |
| EBITDA | 61 | 35 | 67 | 94 | 133 | 152 | 188 |
| +Non-Operating Expenses | 35 | 38 | 34 | 51 | 72 | 77 | 73 |
| Profit Before Tax (PBT) | 31 | 8 | 37 | 51 | 68 | 108 | 139 |
| +Tax Expense | 11 | 1 | 6 | 13 | 19 | 25 | 35 |
| Total Profit for Period | 19 | 6 | 31 | 38 | 49 | 82 | 104 |
| Less: Non-controlling Interests | -0 | — | -0 | -1 | 0 | -0 | 0 |
| Net Profit (Owner's PAT) | 20 | 6 | 32 | 39 | 49 | 83 | 104 |
| Earnings Per Share (EPS) | 1.50 | 0.47 | 2.40 | 2.88 | 3.62 | 6.00 | 6.55 |
| Diluted Shares Outstanding (Nos.) | 13 | 13 | 13 | 13 | 14 | 14 | 16 |
| +Additional Disclosures | 678 | 521 | 863 | 889 | 1,036 | 1,089 | 1,226 |
| Sales Growth % | — | -27.72 | 35.85 | 32.92 | 19.14 | 6.64 | 15.40 |
| YoY Sales Growth % | — | -27.72 | 35.85 | 32.92 | 19.14 | 6.64 | 15.40 |
| Material Cost % | 25 | 28 | 62 | 26 | 25 | 24 | 23 |
| Employee Cost % | 18 | 21 | 19 | 16 | 16 | 16 | 15 |
| Other Cost % | 46 | 42 | 7 | 44 | 44 | 44 | 44 |
| OPM % | 11 | 9 | 12 | 13 | 15 | 16 | 17 |
| Tax % | 36 | 18 | 16 | 25 | 28 | 24 | 25 |
| Profit Growth % | — | -68.88 | 416.47 | 21.32 | 27.32 | 68.14 | 25.41 |
| Gross Margin % | 75.42 | 71.49 | 38.40 | 73.57 | 75.11 | 75.72 | 76.52 |
| EBITDA Margin % | 10.88 | 8.62 | 12.16 | 12.74 | 15.10 | 16.20 | 17.40 |
| Interest Coverage Ratio | 3.03 | 1.06 | 3.78 | 3.20 | 2.95 | 3.34 | 5.06 |
| Ebit | 39 | 14 | 45 | 63 | 92 | 107 | 140 |
Artemis Medicare Services segment analysis: revenue and profit mix.
Disclosed business segments at Artemis Medicare Services with their share of revenue and profit, switchable between consolidated and standalone reporting.
Artemis Medicare Services discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Artemis Medicare Services Limited.
Our AI distills the core fundamental drivers supporting Artemis Medicare Services Limited, the risks that threaten it, and the exact valuation or growth triggers that should make you re-evaluate.
Artemis Medicare Services Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Latest quarterly EPS grew 28.7% TTM, demonstrating robust earnings momentum.
Operating margin 13.85% outpaces Apollo 11.13%, signaling superior operational efficiency.
Quarterly revenue growth 14.20% YoY signals expanding market share consistently.
Promoter holding 58.39% indicates strong insider confidence and long-term commitment.
Debt-to-equity 0.0028x effectively debt-free; minimal financial leverage risk.
Key Risks.
P/E ratio 40.10x elevated versus sector median, suggesting premium valuation.
Minimal dividend yield 0.17% unattractive for income-focused investors.
Net cash flow negative ₹7.97 Cr signals recent cash burn despite operations.
52-week range ₹203.35–₹297.50 shows 46% price volatility limiting upside.
ROE 12.00% and ROCE 14.60% lag Apollo (ROE 22.10%, ROCE 17.90%); room for improvement.
Flip Conditions.
Trim if P/E re-rates above 55. The valuation cushion thins from there.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Income thesis breaks if the dividend is cut or yield falls below 0.09%.
Artemis Medicare Services Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Artemis Medicare Services Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Artemis Medicare Services Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Artemis Medicare Services Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
Artemis Medicare Services Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Artemis Medicare Services Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Artemis Medicare Services Limited stood at 63.7% of traded volume, against a 20-day average of 58.6%.
Artemis Medicare Services announcements: results, concalls, ratings, M&A.
Filings Artemis Medicare Services sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Artemis Medicare Services files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 118 documents below.
Commencement of commercial production/operations
Artemis Medicare Services Limited has informed the Exchange about Commencement of Operations of Artemis Shanti Hospital, Raipur
Copy of Newspaper Publication
Artemis Medicare Services Limited has informed the Exchange about Copy of Newspaper Publication - July 8, 2026
General Updates
Artemis Medicare Services Limited has informed the Exchange about Letter to shareholders containing weblink of Annual Report for the financial year…
Updates
Artemis Medicare Services Limited has informed the Exchange regarding Business Responsibility and Sustainability Report for the financial year ended…
Shareholders meeting
Artemis Medicare Services Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on July 31, 2026
Investor decks & rating reports.
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Investor Presentation
Artemis Medicare Services dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Artemis Medicare Services has declared, sequenced by announce and record date.
Artemis Medicare Services corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Artemis Medicare Services Limited: business, sector, key facts.
What Artemis Medicare Services Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Artemis Medicare Services Limited operates in the Hospital industry under the Healthcare sector, listed as NSE: ARTEMISMED, BSE: 542919.
Artemis Medicare Services Limited is a healthcare provider operating primarily in India, with international expansion. Their core business revolves around the management and operation of multi-specialty hospitals, delivering a comprehensive range of medical services.
The company's flagship facility is Artemis Hospital, a multi-specialty hospital situated in Gurugram, India. This hospital offers a wide spectrum of medical and surgical interventions, catering to both inpatient and outpatient needs. This includes a broad scope of services extending beyond basic medical care.
Beyond direct medical treatment, Artemis provides extensive ancillary services designed to enhance the patient experience and overall healthcare journey. These services encompass billing and insurance assistance, childcare, emotional and support programs, international patient services, translation and record management, nutritional guidance, patient advocacy, pre-admission testing, smoking cessation programs, and executive health checks. They also offer workplace clinics for counseling and various healthcare education and awareness initiatives.
Furthermore, Artemis's service offerings extend to emergency services, first aid and BLS training, and organizational healthcare audits. This diversified approach positions them as a holistic healthcare provider, addressing not only immediate medical needs but also preventative care, patient support, and broader healthcare system optimization.
In summary, Artemis Medicare Services Limited is a vertically integrated healthcare company focused on delivering high-quality medical care and a comprehensive support system. Their business model combines direct patient care with ancillary services aimed at improving the overall patient experience and promoting wellness.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Dr Agarwal's Health Care (AGARWALEYE) Share PricePeer
- Apollo Hospitals Enterprise (APOLLOHOSP) Share PricePeer
- Aster DM Healthcare (ASTERDM) Share PricePeer
- Fortis Healthcare (FORTIS) Share PricePeer
- GPT Healthcare (GPTHEALTH) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Artemis Medicare Services Limited (ARTEMISMED).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Artemis Medicare Services Limited (ARTEMISMED)?
The current share price of Artemis Medicare Services Limited (ARTEMISMED) is ₹276.2. Today, the stock has gained by ₹5.20 (1.92%), trading in a range of ₹271.05 to ₹279.8. The stock opened at ₹271.05 with a trading volume of 1,47,534 shares.
02Is Artemis Medicare Services Limited stock a good investment for long-term?
Artemis Medicare Services Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹4,412.79 crores, P/E ratio of 42.14, ROE of 12.00%, and ROCE of 14.60%. The dividend yield stands at 0.17%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Artemis Medicare Services Limited stock?
The 52-week high price of Artemis Medicare Services Limited (ARTEMISMED) is ₹297.5, while the 52-week low is ₹203.35. Currently trading at ₹276.2, the stock is 77.4% away from its 52-week low and 7.2% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Artemis Medicare Services Limited stock at the current price?
Whether to buy Artemis Medicare Services Limited stock at ₹276.2 depends on multiple factors. The stock is currently trading with a P/E ratio of 42.14 and P/B ratio of 4.67. Today's performance shows a gain of 1.92%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Artemis Medicare Services Limited and when is the next dividend?
Artemis Medicare Services Limited offers a dividend yield of 0.17%, which means for every ₹100 invested at the current price of ₹276.2, you can expect to receive approximately ₹0.17 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Artemis Medicare Services Limited?
Artemis Medicare Services Limited's key financial metrics include: P/E Ratio: 42.14, P/B Ratio: 4.67, ROE: 12.00%, ROCE: 14.60%, Dividend Yield: 0.17%, EPS: ₹2.29, Book Value: ₹59.16, and Debt-to-Equity: 0.00. The company's market cap stands at ₹4,412.79 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Artemis Medicare Services Limited stock performing today in the market?
Artemis Medicare Services Limited stock opened at ₹271.05 and is currently trading at ₹276.2, showing a gain of ₹5.20 (1.92%). The intraday high is ₹279.8 and low is ₹271.05. The trading volume stands at 1,47,534 shares, indicating moderate market participation today.
08What is the P/E ratio of Artemis Medicare Services Limited and what does it indicate?
Artemis Medicare Services Limited has a Price-to-Earnings (P/E) ratio of 42.14, which means investors are willing to pay ₹42.14 for every ₹1 of earnings. With an EPS of ₹2.29, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Artemis Medicare Services Limited (ARTEMISMED) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.